Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Cryptococcosis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Table of Content

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Cryptococcosis Market Snapshot 

4. Market Overview
     4.1. Product Overview
     4.2. Market Indicators 
     4.3. Global Cryptococcosis Market Size (US$ Mn) Forecast, 2014–2024 
     4.4. Global Cryptococcosis Market Outlook 
     4.5. Key Industry Events 
     4.6. Global Cryptococcosis Incidence Scenario-2015, by Region 
     4.7. Overview of Clinical Trials 

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
            5.2.1. Increasing incidence of cryptococcosis infections
            5.2.2. Rising initiatives by government and non-government organizations
            5.2.3. Impetus from HIV patients
            5.2.4. Improved access to diagnostic facilities
     5.3. Restraints
            5.3.1. High mortality among cryptococcosis infected patients
            5.3.2. Patent expiry of key drugs and entry of generics
     5.4. Opportunity Analysis
     5.5. Opportunities
            5.5.1. Setting up integrated facilities in high-potential markets
            5.5.2. Investment inflow and mergers & acquisitions

6. Global Cryptococcosis Market Analysis, by Treatment
     6.1. Introduction
     6.2. Key Findings
     6.3. Global Cryptococcosis Market Value Share Analysis, by Treatment, 2016-2024 
            6.3.1. Amphotericin B
            6.3.2. Flucytosine
            6.3.3. Fluconazole
            6.3.4. Others (Voriconazole, surgery treatment, etc.)
     6.4. Global Cryptococcosis Market Attractiveness Analysis, by Treatment, 2014–2024
     6.5. Key Trends

7. Global Cryptococcosis market Analysis, by Distribution Channel
     7.1. Introduction
     7.2. Key Findings
     7.3. Global Cryptococcosis Market Value Share Analysis, by Distribution Channel, 2016 -2024
            7.3.1. Hospital Pharmacies
            7.3.2. Retail Pharmacies
            7.3.3. Drug Store
            7.3.4. Mail Order Pharmacies
            7.3.5. Others
     7.4. Cryptococcosis Market Attractiveness Analysis, by Distribution Channel, 2014-2024
     7.5. Key Trends

8. Global Cryptococcosis Market Analysis, by Region
     8.1. Global Market Scenario by Country
     8.2. Global Cryptococcosis Market Value Share Analysis, by Region, 2016 and 2024 

9. North America Cryptococcosis Market Analysis
     9.1. Key Findings
     9.2. Market Overview
     9.3. North America Cryptococcosis Market Value Share Analysis, by Country
     9.4. North America Cryptococcosis Market Value Share Analysis, by Treatment 
     9.5. North America Cryptococcosis Market Value Share Analysis, by Distribution Channel 
     9.6. North America Cryptococcosis Market Attractiveness Analysis 
     9.7. Key Trends 

10. Middle East & Africa Cryptococcosis Market Analysis
     10.1. Key Findings
     10.2. Market Overview
     10.3. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Country
     10.4. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Treatment 
     10.5. Middle East & Africa Cryptococcosis Market Value Share Analysis, by Distribution Channel 
     10.6. Middle East & Africa Cryptococcosis Market Attractiveness Analysis 
     10.7. Key Trends 

11. Asia Pacific Cryptococcosis Market Analysis
     11.1. Key Findings
     11.2. Asia Pacific Cryptococcosis Market Overview
     11.3. Asia Pacific Cryptococcosis Market Value Share Analysis, by Country 
     11.4. Asia Pacific Cryptococcosis Market Value Share Analysis, by Treatment 
     11.5. Asia Pacific Cryptococcosis Market Value Share Analysis, by Distribution Channel
     11.6. Asia Pacific Cryptococcosis Market Attractiveness Analysis 
     11.7. Key Trends

12. Europe Cryptococcosis market Analysis
     12.1. Key Findings
     12.2. Market Overview
     12.3. Europe Cryptococcosis Market Value Share Analysis, by Country
     12.4. Europe Cryptococcosis Market Value Share Analysis, by Treatment 
     12.5. Europe Cryptococcosis Market Value Share Analysis, by Distribution Channel 
     12.6. Europe Cryptococcosis Market Attractiveness Analysis 
     12.7. Key Trends 

13.  Latin America Cryptococcosis market Analysis
     13.1. Key Findings
     13.2. Market Overview     
     13.3. Latin America Cryptococcosis Market Value Share Analysis, by Country
     13.4. Latin America Cryptococcosis Market Value Share Analysis, by Treatment 
     13.5. Latin America Cryptococcosis Market Value Share Analysis, by Distribution Channel 
     13.6. Latin America Cryptococcosis Market Attractiveness Analysis 
     13.7. Key Trends 

14. Competition Landscape
     14.1. Cryptococcosis Market Share Analysis By Company, 2016 (Estimated)
     14.2. Competition Matrix
     14.3. Company Profiles
            14.3.1. Bristol-Myers Squibb Company
                      14.3.1.1. Company Details
                      14.3.1.2. Business Overview
                      14.3.1.3. Financial Overview
                      14.3.1.4. Strategic Overview
                      14.3.1.5. SWOT Analysis
            14.3.2. Janssen Biotech, Inc. (Johnson & Johnson)
                      14.3.2.1. Company Details
                      14.3.2.2. Business Overview
                      14.3.2.3. Financial Overview
                      14.3.2.4. Strategic Overview
                      14.3.2.5. SWOT Analysis
            14.3.3. Abbott Laboratories
                      14.3.3.1. Company Details
                      14.3.3.2. Business Overview
                      14.3.3.3. Financial Overview
                      14.3.3.4. Strategic Overview
                      14.3.3.5. SWOT Analysis
            14.3.4. Novartis AG
                      14.3.4.1. Company Details
                      14.3.4.2. Business Overview
                      14.3.4.3. Financial Overview
                      14.3.4.4. Strategic Overview
                      14.3.4.5. SWOT Analysis
            14.3.5. Pfizer, Inc.
                      14.3.5.1. Company Details
                      14.3.5.2. Business Overview
                      14.3.5.3. Financial Overview
                      14.3.5.4. Strategic Overview
                      14.3.5.5. SWOT Analysis
            14.3.6. Valeant Pharmaceuticals, Inc.
                      14.3.6.1. Company Details
                      14.3.6.2. Business Overview
                      14.3.6.3. Financial Overview
                      14.3.6.4. Strategic Overview
                      14.3.6.5. SWOT Analysis
            14.3.7. Glenmark Pharmaceuticals
                      14.3.7.1. Company Details
                      14.3.7.2. Business Overview
                      14.3.7.3. Financial Overview
                      14.3.7.4. Strategic Overview
                      14.3.7.5. SWOT Analysis
            14.3.8. Viamet Pharmaceuticals, Inc.
                      14.3.8.1. Company Details
                      14.3.8.2. Business Overview
                      14.3.8.3. Financial Overview
                      14.3.8.4. Strategic Overview
                      14.3.8.5. SWOT Analysis
            14.3.9. Sigmapharm Laboratories LLC
                      14.3.9.1. Company Details
                      14.3.9.2. Business Overview
                      14.3.9.3. Financial Overview
                      14.3.9.4. Strategic Overview
                      14.3.9.5. SWOT Analysis

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote